Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million installment payment related to the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback